4 September 2018 in Current Medicinal Chemistry
SNSadrine Tchoukouegno Ngeu
Sadrine Tchoukouegno Ngeu
CACharline Florence Awounfack
Charline Florence Awounfack
+1
Background: The approval of Taxol® in 1993 marked the great entrance of terpenoids in the anti-cancer area and this drug is still highly important in the treatment of refractory ovarian, breast and other cancers. Over decades, other prominent natural terpenoids have become indispensable for the modern pharmacotherapy of breast cancer. However, given the rapid evolution of drug resistance, effective treatments for advanced breast cancers requiring cytotoxic chemotherapy represent a major unmet clinical need. Therefore, innovative agents effective in long-term chemotherapy are urgently needed. Objective: This review examines recent advances/research about natural terpenoids, and their mechanisms against female breast cancer over the period covering January 1st, 2012 to December 31st, 2016. Results: Carcinogenesis constitutes a multistep process wherein each stage is characterized by distinct phenotypic changes. Numerous chemicals recorded in this review have been shown to significantly inhibit proliferation, migration, apoptosis resistance, tumor angiogenesis or metastasis in different breast cancer cells/tumours in vitro and in vivo. Targeting simultaneously several or all these aspects/steps of cancer progression could be an advantage. In line with this, phytochemicals such as thymoquinone (8), costunolide (46), tanshinone IIA (132), triptolide (136), cucurbitacin B (179), celastrol (226) and lycopene (238) had caught our attention. Conclusion: These compounds appear to be promising to overcome breast cancer treatment failure. However, despite the interesting activities, additional preclinical investigations are needed in further breast cancer cell/tumor models in vitro and in vivo.
10 September 2019 in Frontiers in Pharmacology
Over the last decade, several studies demonstrated that prenylation of flavonoids enhances various biological activities as compared to the respective non-prenylated compounds. In line with this, the natural prenylated isoflavonoid alpinumisoflavone (AIF) has been explored for a number of biological and pharmacological effects (therapeutic potential). In this review, we attempt to summarize the current information and health-promoting properties of AIF. Reported data evidenced that AIF has a multi-therapeutic potential with anti-osteoporotic, anti-oxidant and anti-inflammatory, anti-microbial, anti-cancer, estrogenic and anti-estrogenic, anti-diabetic and neuroprotective properties. However, research on these aspects of AIF is not sufficient and somehow need to be reevaluated using more appropriate methods and methodology. Further series of studies are therefore needed to enrich the knowledge of these pharmacological effects. Overall, despite the drawbacks of studies recorded, AIF exhibits a potential as drug candidate.
1 January 2014 in Toxicology Reports
OMOumarou Riepouo Mouchili
+2
Amphimas pterocarpoides Harms (Leguminosae) is widely used traditionally in Central and West Africa for the treatment of various ailments. However, no data regarding its safety have been published until now. Thus, the present study aimed to investigate the potential toxicity of the methanol extract of the stem bark of Amphimas pterocarpoides (AP) in Wistar rats following the OECD guidelines. In acute oral toxicity, female rats received a single dose of 2000 mg/kg of AP and were observed for 14 days. In subchronic toxicity, doses of 150, 300, 600 mg/kg/day of AP were given per os to rats (males and females) for 28 days. No death and abnormal behaviors were observed in acute toxicity and the LD50 was estimated higher than 5000 mg/kg. In the subchronic study, AP induced no significant variation in body weight and relative weight of organs, whereas a delayed decrease of white blood cell count and granulocytes was observed. Inconsistent increase of the total cholesterol/high density lipoprotein was observed at 600 mg/kg in males. Such variation (not dose dependent) and without biological relevance indicate a wide margin of safety for the traditional use of AP.
31 August 2016 in Journal of Ethnopharmacology
CACharline Florence Awounfack
Charline Florence Awounfack
OMOumarou Riepouo Mouchili
1 October 2013 in Journal of Ethnopharmacology
1 March 2014 in Food and Chemical Toxicology